Key points are not available for this paper at this time.
Supports AVNA for refractory AF symptoms; leaves open outcome benefits in reduced EF pending RCTs.
In the management of refractory AF, AVNA is associated with improvement in symptoms and quality of life, with a low incidence of procedure morbidity. In patients with reduced systolic function, AVNA demonstrates small but significantly improved echocardiographic outcomes relative to medical therapy alone.
No takes yet. Share an insight, caveat, or question.
Chatterjee et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: